Traditional Chinese medicine versus regular therapy in Henoch-Sch ├Ânlein purpura nephritis in children: study protocol for a randomized controlled trial
This study was performed to evaluate the curative effect and safety of a traditional Chinese me dicine (TCM) integrated treatment program in this type of HSPN.MethodsThis multicenter, open-label, large-sample, randomized controlled trial was performed in China and included 500 children with HSPN exhibiting mild pathological patterns. The treatment group to control group ratio was 2:1, and each group was further stratified into two types, light and heavy, according to urinary protein quantification and pathological type. The treatment group received tripterygium glycosides (TGs), tanshinone IIa sodium sulfonate injection, a...
Source: Trials - August 29, 2019 Category: Research Source Type: clinical trials

Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors
Conditions:   Hypertension;   Unspecified Adult Solid Tumor, Protocol SpecificInterventions:   Drug: lisinopril;   Drug: losartan potassium;   Other: laboratory biomarker analysis;   Drug: benazepril hydrochloride;   Drug: ramiprilSponsor:   Comprehensive Cancer Center of Wake Forest UniversityTerminated - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2010 Category: Research Source Type: clinical trials

Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency
Condition:   Renal Insufficiency, ChronicInterventions:   Drug: Benazepril;   Drug: Losartan;   Drug: Benazepril+LosartanSponsor:   Nanfang Hospital of Southern Medical UniversityRecruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2008 Category: Research Source Type: clinical trials

Preventing Microalbuminuria in Type 2 Diabetes
Condition:   DiabetesInterventions:   Drug: Benazepril;   Drug: Valsartan;   Drug: Benazepril/ValsartanSponsors:   Mario Negri Institute for Pharmacological Research;   Agenzia Italiana del FarmacoActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2007 Category: Research Source Type: clinical trials

Preventing ESRD in Overt Nephropathy of Type 2 Diabetes
Condition:   DiabetesInterventions:   Drug: Benazepril;   Drug: Valsartan;   Drug: Benazepril/ValsartanSponsors:   Mario Negri Institute for Pharmacological Research;   Agenzia Italiana del FarmacoActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2007 Category: Research Source Type: clinical trials